Entrada Therapeutics, Inc.

TRDA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001689375

SEC filings (opens in a new tab)

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Entrada Therapeutics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of TRDA: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Q3 2025	Change
Holders	107	116	+9
Shares	29.6M	28.5M	−1.11M (−3.7%)
Value	$198.8M	$164.8M	−$34.0M (−17.1%)

New holders (25)

Institutions that held Entrada Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to TRDA in Q3 2025
Institution	Shares	Value	% of portfolio
Algert Global LLC	129,812	$752.9K	0.01%
Cubist Systematic Strategies, LLC	122,676	$711.5K	0.01%
Two Sigma Investments, LP	93,194	$540.5K	0.00%
XTX Topco Ltd	93,079	$539.9K	0.03%
D. E. Shaw & Co., Inc.	71,548	$415.0K	0.00%
Gsa Capital Partners LLP	55,960	$325.0K	0.03%
Two Sigma Advisers, LP	51,500	$298.7K	0.00%
Great Lakes Advisors, LLC	41,029	$238.0K	0.00%
Bridgeway Capital Management, LLC	40,000	$232.0K	0.00%
Atom Investors LP	30,812	$178.7K	0.01%
Oxford Asset Management LLP	29,161	$169.1K	0.06%
Prelude Capital Management, LLC	25,754	$149.4K	0.01%
HSBC Holdings PLC	20,639	$117.2K	0.00%
Sherbrooke Park Advisers LLC	18,573	$107.7K	0.05%
Quadrature Capital Ltd	17,894	$103.4K	0.00%
GWM Advisors LLC	14,167	$82.2K	0.00%
Jain Global LLC	11,954	$69.3K	0.00%
Inscription Capital, LLC	11,835	$68.6K	0.01%
Axq Capital, LP	11,570	$67.1K	0.03%
Point72 (DIFC) Ltd	1,358	$7.88K	0.00%
The PNC Financial Services Group, Inc.	1,157	$6.71K	0.00%
Optiver Holding B.V.	346	$2.01K	0.00%
Private Wealth Management Group, LLC	212	$1.23K	0.00%
UBS Asset Management Americas Inc	111	$644	0.00%
Cantor Fitzgerald, L. P.	67,334	–	–

Sold out (16)

Institutions that held Entrada Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of TRDA in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Janus Henderson Group PLC	1,521,281	$10.2M
Arrowstreet Capital, Limited Partnership	102,008	$685.5K
Massachusetts Financial Services Co	87,387	$587.2K
First Trust Advisors LP	75,120	$504.8K
Prudential Financial Inc	28,340	$190.4K
Dynamic Technology Lab Private Ltd	24,734	$166.0K
Man Group plc	16,805	$112.9K
ExodusPoint Capital Management, LP	15,785	$106.0K
Harbor Capital Advisors, Inc.	15,277	$103.0K
Squarepoint Ops LLC	11,208	$75.3K
State of Wyoming	7,575	$50.9K
US Bancorp	2,868	$19.3K
Lazard Asset Management LLC	1,256	$8.00K
Skopos Labs, Inc.	393	$2.64K
Allworth Financial LP	62	$417
Signaturefd, LLC	53	$356